International Conference
Alzheimer’s Disease - From Basic Research to Clinical Applications
Leipzig / Germany , June 4 - 7 1997
Neues Gewandhaus
e-mail: alz97 at server3.medizin.uni-leipzig.dehttp://www.uni-leipzig.de/medizin/alz97
Preliminary Program
Wednesday, June 4
19.00 - 21.00 Opening ceremony, Honory lecture
Sir Martin Roth, Cambridge
Thursday, June 5
9.00 - 12.00 Longitudinal Studies / Progression of the Disease
L. Gustafson, Kopenhagen
Clinical Manifestations and heterogeneity of AD
K.Jobst, Oxford
The course of AD
B. Reisberg, New York
Variability of progression in AD
B. Winblad, Stockholm
Mild cognitive decline - an early stage of AD?
H.-J. Gertz, Leipzig
Mild cognitve decline and its implications for therapeutic
interventions
I.G. McKeith, Newcastle
What are the relations between Lewy body disease and AD?
Ph. Scheltens, Amsterdam
The influence of coincidental vascular pathology on symptomatology
and course of AD
13.45 - 14.55 poster presentations / oral presentation of selected
posters
15.00 - 18.00 Pathogenetic theories and therapeutic approaches (part I)
free radicals: P. Riederer, Wuerzburg; M. Roesler, Wuerzburg
calcium metabolism: W.E. Mueller, Mannheim; R. Ihl, Duesseldorf
glucose metabolism: S. Hoyer, Heidelberg; S. Kanowski, Berlin
19.00 Concert, St Thomas` Church, afterwards Gala Dinner Auerbachs
Keller
Friday, June 6
8.30 - 12.00 Symposium - Significance of tau and amyloid pathology
K. Jellinger, Vienna
Introduction
V.M.-Y. Lee, Pennsylvania
Pathology of tau
R. Nitsch, Hamburg
APP and formation of ßA4
C.M. Wischik, Cambridge
Therapeutic strategies deriving from tau-pathology
Th. Arendt, Leipzig
Alterations in signal transduction
11.00 - 12.00 Round table discussions:
Consequences of tau and amyloid research for therapeutic strategies
13.45 - 14.55 oral presentation of selected posters
15.00 - 18.00 Pathogenetic theories and therapeutic approaches (part
II)
Immunpathology P. Schubert, Muenchen; H.-J. Moeller, Muenchen
cholinergic deficit V. Bigl, Leipzig; A. Kurz, Muenchen
glutamergic system J. Kornhuber, Goettingen C.G. Gottfries, Goeteburg
Saturday, June 7
9.00 - 12.00 Symposium - Risk factors and Prevention
Ch. Haas, Mannheim
Genetics of AD
J. Poirier, Montreal
Apo E as a risk factor and predictor of therapeutic efficacy
A.J. Holland, Cambridge
Is Down ‘s Syndrome a suitable modell of AD?
H. Braak, Frankfurt/M
Senile Dementia - an early onset disease?
P. McGeer, Vancouver
The role of antiininflammatory agents in the treatment of AD
12.00 - 13.00 Round table discussions:
The problem of aetiological heterogeneity and its relevance for
preventive and therapeutic strategies
Organizing Societies:
University of Leipzig, Clinic of Psychiatry, Paul Flechsig Institute for
Brain Research and Interdisciplinary Centre for Clinical Research
Leipzig
together with:
Arbeitsgemeinschaft fuer Neuropsychopharmakologie und
Pharmakopsychiatrie (AGNP)
Deutsche Gesellschaft fuer Biologische Psychiatry (DGBP)
Hirnliga e.V.
Deutsche Alzheimer Gesellschaft e.V.
Alzheimer Gesellschaft Leipzig e.V.
Organizers:
Hermann-Josef Gertz
Thomas Arendt
Secretariat:
University of Leipzig, Clinic for Psychiatry
Emilienstr. 14
04107 Leipzig / Germany
phone: +49 341 9724500
fax +49 341 9724509
e-mail: alz97 at server3.medizin.uni-leipzig.de
www: http://www.uni-leipzig.de/medizin/alz97
